LifeMD (LFMD) Capital Expenditures (2020 - 2025)

LifeMD (LFMD) has reported Capital Expenditures for 6 consecutive years, with -$798228.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Capital Expenditures rose 1.16% year-over-year to -$798228.0; the trailing twelve-month figure through Dec 2025 stood at $7.6 million (up 13.49% YoY), and the FY2025 full-year result was $7.6 million, up 13.49% from the prior year.
• Capital Expenditures retreated to -$798228.0 in Q4 2025 per LFMD's latest filing, from $2.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $3.0 million in Q3 2024 and bottomed at -$807604.0 in Q4 2024.
• Historically, Capital Expenditures has averaged $1.7 million across 5 years, with a median of $2.1 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 4194.19% in 2022, then tumbled 138.32% in 2024.
• Over 5 years, Capital Expenditures stood at $1.4 million in 2021, then increased by 27.27% to $1.8 million in 2022, then climbed by 18.17% to $2.1 million in 2023, then sank by 138.32% to -$807604.0 in 2024, then gained by 1.16% to -$798228.0 in 2025.
• According to Business Quant data, Capital Expenditures over the past three periods registered -$798228.0, $2.8 million, and $2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.